Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03111316 · ClinicalTrials.gov registry record · NA

Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening

A NA study of Cervical Ripening and Induction of Labor, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03111316 is a NA study of Cervical Ripening and Induction of Labor that has completed, run by University of Oklahoma. The registered enrollment target is 100 participants, below the 458-participant average among 8 other Cervical Ripening trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03111316, a NA study of Cervical Ripening and Induction of Labor, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

In term women presenting for labor induction, combined use of the controlled release dinoprostone vaginal insert and Foley catheter for cervical ripening will decrease the median time from induction to vaginal delivery by at least four hours compared to the Foley catheter alone.

Interventions

  • DEVICE Foley Catheter
  • DRUG Cervidil 10 MG Vaginal Insert

Study Locations (1)

Oklahoma

  • The University of Oklahoma Health Sciences Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2017-04-09
Est. Completion 2020-07-24
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT03111316

The ClinicalTrials.gov registry entry for NCT03111316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 458-participant average among 8 other Cervical Ripening trials with a reported enrollment target (78% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cervical Ripening appearing as the primary indexed condition, and to 2 interventions - of which Foley Catheter is the first listed.

NCT03111316 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT03111316 about?

NCT03111316 is a clinical study titled "Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening". In term women presenting for labor induction, combined use of the controlled release dinoprostone vaginal insert and Foley catheter for cervical ripening will decrease the median time from induction to vaginal delivery by at least four hours compared to the Foley catheter alone.

What is the current status of trial NCT03111316?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-04-09. Estimated completion is 2020-07-24.

What conditions does trial NCT03111316 study?

This clinical trial studies the following conditions: Cervical Ripening, Induction of Labor.

What interventions are being tested in trial NCT03111316?

The interventions under investigation include: Foley Catheter (DEVICE), Cervidil 10 MG Vaginal Insert (DRUG).

Who is sponsoring clinical trial NCT03111316?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03111316 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Ripening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.